Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 6
|
pp. 5027–5037
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Back to article
Figure 4
(4 of 7)
−
100%
+
Figure 4.
PHN-20 inhibited the NLRP3 signaling in lung tissues of PAH rats.
(
A
) Protein level of NLRP3. (
B
) Protein level of ASC. (**, P<0.01 vs. control group; #, ##, P<0.05, 0.01 vs. hypoxia group).